Our office has published a new book, Testosterone therapy’s link to heart attack, stroke, and death: what you need to know. The iBook is available for free through iTunes and is the first to be published on the dangers of testosterone replacement gel therapy.
Recent studies have shown that testosterone replacement therapy can double or even triple the risk of heart attack, stroke, or other cardiac problems in men aged 65 and older.
Millions of men have received some form of testosterone replacement therapy without understanding the risk and danger involved. Drug makers have spent years marketing not just the testosterone replacement gels, but actually selling the disease. These drug companies created a 10 question quiz (originally written on toilet paper) that is designed so that nearly every person who takes the quiz (even women) will fail and can then “self-diagnose” as having testosterone deficiency.
Testosterone replacement products have been marketed under a variety of brand names:
- Androdgel
- Androderm
- Axiron
- Bio-T-Gel
- Delastryl
- Depo-Testosterone
- Fortesta
- Striant
- Testim
- Testopoel
Our new book – available as a free download through Apple’s iBooks – takes a closer look at the development of testosterone replacement gels and the serious side effects that have been documented in recent studies. Download the book today for more information about testosterone gel therapy.
Read More:
- Testosterone Gel Linked to Increased Heart Attack Risk
- Testosterone Therapy: Off-Label Promotion, Dangerous Side Effects, & Stephen Colbert
© Copyright 2014 Brett A. Emison
Follow @BrettEmison on Twitter.
Brett Emison is currently a partner at Langdon & Emison, a firm dedicated to helping injured victims across the country from their primary office near Kansas City. Mainly focusing on catastrophic injury and death cases as well as complex mass tort and dangerous drug cases, Mr. Emison often deals with automotive defects, automobile crashes, railroad crossing accidents (train accidents), trucking accidents, dangerous and defective drugs, defective medical devices.
Comments for this article are closed.